Literature DB >> 23196976

O blood group is a risk factor for severe mucosal hemorrhage in orally anticoagulated patients.

Massimo Franchini1, Chiara Rossi, Carlo Mengoli, Moreno Meschieri, Francesco Frattini, Silvia Crestani, Ivano Giacomini, Mario Luppi, Carlo Bonfanti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23196976     DOI： 10.1007/s11239-012-0855-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  11 in total

1.  Relationship between ABO blood group and bleeding complications in orally anticoagulated patients.

Authors:  M Franchini; S Crestani; F Frattini; C Mengoli; C Bonfanti
Journal:  J Thromb Haemost       Date:  2012-08       Impact factor: 5.824

2.  The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment.

Authors:  A A Garcia; J F van der Heijden; J C M Meijers; F R Rosendaal; P H Reitsma
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

3.  O blood group and the risk of major bleeding: a single-center survey.

Authors:  Massimo Franchini; Silvia Crestani; Chiara Rossi; Francesco Frattini; Carlo Mengoli; Ivano Giacomini; Mario Luppi; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-01       Impact factor: 2.300

Review 4.  Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis.

Authors:  Francesco Dentali; Anna Paola Sironi; Walter Ageno; Carlo Bonfanti; Silvia Crestani; Francesco Frattini; Luigi Steidl; Massimo Franchini
Journal:  Semin Thromb Hemost       Date:  2013-01-08       Impact factor: 4.180

5.  Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.

Authors:  D M O Pruissen; F R Rosendaal; J W Gorter; A A Garcia; L J Kappelle; A Algra
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

6.  Reporting results of cancer treatment.

Authors:  A B Miller; B Hoogstraten; M Staquet; A Winkler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

Review 7.  Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature.

Authors:  Francesco Dentali; Anna Paola Sironi; Walter Ageno; Sara Turato; Carlo Bonfanti; Francesco Frattini; Silvia Crestani; Massimo Franchini
Journal:  Semin Thromb Hemost       Date:  2012-06-27       Impact factor: 4.180

Review 8.  Von Willebrand factor: another janus-faced hemostasis protein.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Semin Thromb Hemost       Date:  2008-12-15       Impact factor: 4.180

9.  The effect of ABO blood group on the diagnosis of von Willebrand disease.

Authors:  J C Gill; J Endres-Brooks; P J Bauer; W J Marks; R R Montgomery
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

Review 10.  ABO blood group, hypercoagulability, and cardiovascular and cancer risk.

Authors:  Massimo Franchini; Emmanuel J Favaloro; Giovanni Targher; Giuseppe Lippi
Journal:  Crit Rev Clin Lab Sci       Date:  2012-08-03       Impact factor: 6.250
View more
  2 in total

1.  O blood type is a risk factor for upper gastrointestinal bleeding.

Authors:  Massimo Franchini; Thomas Togliani; Rosalia Turdo; Giuseppe Lucchini; Carlo Bonfanti; Ivano Giacomini; Mario Luppi; Stefano Pilati
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

2.  Evaluation of blood type as a potential risk factor for early postpartum hemorrhage.

Authors:  Mais Ali-Saleh; Ofer Lavie; Yoram Abramov
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.